Effect of <scp>CYP</scp> 4F2 , <scp>VKORC</scp> 1 , and <scp>CYP</scp> 2C9 in Influencing Coumarin Dose: A Single‐Patient Data Meta‐Analysis in More Than 15,000 Individuals

Elisa Danese, Sara Raimondi, Martina Montagnana, Angela Tagetti, Taimour Langaee, Paola Borgiani, Cinzia Ciccacci, Antonio J. Carcas, Alberto M. Borobia, Hoi Y. Tong, Cristina Lucía Dávila-Fajardo, Mariana Rodrigues Botton, Stéphane Bourgeois, Panos Deloukas, Michael D. Caldwell, J. K. Burmester, Richard L. Berg, Larisa H. Cavallari, Katarzyna Drozda, Min Huang, Lizi Zhao, Hanjing Cen, Rocío Gónzález‐Conejero, Vanessa Roldán, Yusuke Nakamura, Taisei Mushiroda, Inna Y. Gong, Richard B. Kim, Keita Hirai, Kunihiko Itoh, Carlos Alberto Arias, Leonardo Beltrán, Enrique Jiménez‐Varo, Marisa Cañadas‐Garre, Alice Giontella, Marianne Kristiansen Kringen, Kari Bente Foss Haug, Hye Sun Gwak, Kyung Eun Lee, Pietro Minuz, Ming Ta Michael Lee, Steven A. Lubitz, Stuart A. Scott, Cristina Mazzaccara, Lucia Sacchetti, E. Genç, Mahmut Özer, Anil Pathare, Rajagopal Krishnamoorthy, Andràs Páldi, Virginie Siguret, Marie‐Anne Loriot, Vijay Kumar Kutala, Guilherme Suarez‐Kurtz, Jamila Alessandra Perini, Joshua C. Denny, Andrea H. Ramirez, Balraj Mittal, Saurabh Singh Rathore, Hersh Sagreiya, Russ B. Altman, Mohamed H. Shahin, Sherief Khalifa, Nita A. Limdi, Charles Rivers, Aditi Shendre, Chrisly Dillon, Ivet Suriapranata, Honghao Zhou, Shenglan Tan, Vacis Tatarūnas, Vaiva Lesauskaitė, Yumao Zhang, Anke H. Maitland‐van der Zee, Talitha I. Verhoef, Anthonius de Boer, Monica Taljaard, Carlo‐Federico Zambon, Vittorio Pengo, Jieying Eunice Zhang, Munir Pirmohamed, Julie A. Johnson, Cristiano FavaClinical 2018 · DOI

Abstract

The cytochrome P450 (CYP)4F2 gene is known to influence mean coumarin dose. The aim of the present study was to undertake a meta-analysis at the individual patients level to capture the possible effect of ethnicity, gene-gene interaction, or other drugs on the association and to verify if inclusion of CYP4F2*3 variant into dosing algorithms improves the prediction of mean coumarin dose. We asked the authors of our previous meta-analysis (30 articles) and of 38 new articles retrieved by a systematic review to send us individual patients' data. The final collection consists of 15,754 patients split into a derivation and validation cohort. The CYP4F2*3 polymorphism was consistently associated with an increase in mean coumarin dose (+9% (95% confidence interval (CI) 7-10%), with a higher effect in women, in patients taking acenocoumarol, and in white patients. The inclusion of the CYP4F2*3 in dosing algorithms slightly improved the prediction of stable coumarin dose. New pharmacogenetic equations potentially useful for clinical practice were derived.
BibTeX
@inproceedings{danese2018effect,
  author = {Elisa Danese and Sara Raimondi and Martina Montagnana and Angela Tagetti and Taimour Langaee and Paola Borgiani and Cinzia Ciccacci and Antonio J. Carcas and Alberto M. Borobia and Hoi Y. Tong and Cristina Lucía Dávila-Fajardo and Mariana Rodrigues Botton and Stéphane Bourgeois and Panos Deloukas and Michael D. Caldwell and J. K. Burmester and Richard L. Berg and Larisa H. Cavallari and Katarzyna Drozda and Min Huang and Lizi Zhao and Hanjing Cen and Rocío Gónzález‐Conejero and Vanessa Roldán and Yusuke Nakamura and Taisei Mushiroda and Inna Y. Gong and Richard B. Kim and Keita Hirai and Kunihiko Itoh and Carlos Alberto Arias and Leonardo Beltrán and Enrique Jiménez‐Varo and Marisa Cañadas‐Garre and Alice Giontella and Marianne Kristiansen Kringen and Kari Bente Foss Haug and Hye Sun Gwak and Kyung Eun Lee and Pietro Minuz and Ming Ta Michael Lee and Steven A. Lubitz and Stuart A. Scott and Cristina Mazzaccara and Lucia Sacchetti and E. Genç and Mahmut Özer and Anil Pathare and Rajagopal Krishnamoorthy and Andràs Páldi and Virginie Siguret and Marie‐Anne Loriot and Vijay Kumar Kutala and Guilherme Suarez‐Kurtz and Jamila Alessandra Perini and Joshua C. Denny and Andrea H. Ramirez and Balraj Mittal and Saurabh Singh Rathore and Hersh Sagreiya and Russ B. Altman and Mohamed H. Shahin and Sherief Khalifa and Nita A. Limdi and Charles Rivers and Aditi Shendre and Chrisly Dillon and Ivet Suriapranata and Honghao Zhou and Shenglan Tan and Vacis Tatarūnas and Vaiva Lesauskaitė and Yumao Zhang and Anke H. Maitland‐van der Zee and Talitha I. Verhoef and Anthonius de Boer and Monica Taljaard and Carlo‐Federico Zambon and Vittorio Pengo and Jieying Eunice Zhang and Munir Pirmohamed and Julie A. Johnson and Cristiano Fava},
  title = {{Effect of <i> <scp>CYP</scp> 4F2 </i> , <i> <scp>VKORC</scp> 1 </i> , and <i> <scp>CYP</scp> 2C9 </i> in Influencing Coumarin Dose: A Single‐Patient Data Meta‐Analysis in More Than 15,000 Individuals}},
  booktitle = {Clinical},
  year = {2018},
  doi = {10.1002/cpt.1323},
}

Loading related content...

Figure